Alopexx, Inc. (NASDAQ:ALPX) IPO will take place October, 07 on the NASDAQ exchange under the ticker ALPX.

The company is offering shares at an expected price of $5.00 per share with an insider lock-up period of 180 days ending on April 05, 2023.

See also: Benzinga IPO Calendar

About Alopexx, Inc.

Alopexx, Inc.is a clinical stage biotechnology company developing novel immune therapeutics for the prevention, treatment and mitigation of bacterial, fungal, and parasitic infections that express the antigenic target poly N-acetyl glucosamine.

See also: Benzinga's Most Shorted Stocks

This article was generated by Benzinga's automated content engine and reviewed by an editor.